Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition

ARID1A mutations are observed in various tumors, including ovarian clear cell (OCCC) and endometrioid carcinomas, endometrial, and breast carcinomas. They commonly result in loss of ARID1A-protein expression and frequently co-occur with PI3K/AKT-pathway activating mechanisms. The aim of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Samartzis, Eleftherios P, Gutsche, Katrin, Dedes, Konstantin J, Fink, Daniel, Stucki, Manuel, Imesch, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170604/
https://www.ncbi.nlm.nih.gov/pubmed/24979463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170604/
https://www.ncbi.nlm.nih.gov/pubmed/24979463

Ejemplares similares